Northwest Biotherapeutics Inc (NWBO)
0.4730
-0.01
(-1.49%)
USD |
OTCM |
Apr 23, 10:32
Northwest Biotherapeutics Cash from Investing (TTM): -3.437M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.437M |
September 30, 2023 | -5.179M |
June 30, 2023 | -5.018M |
March 31, 2023 | -4.177M |
December 31, 2022 | -2.902M |
September 30, 2022 | -2.295M |
June 30, 2022 | -4.71M |
March 31, 2022 | -5.809M |
December 31, 2021 | -6.015M |
September 30, 2021 | -7.496M |
June 30, 2021 | -8.607M |
March 31, 2021 | -8.344M |
December 31, 2020 | -8.142M |
September 30, 2020 | -5.222M |
June 30, 2020 | -1.441M |
March 31, 2020 | -0.258M |
December 31, 2019 | -0.36M |
September 30, 2019 | 45.16M |
June 30, 2019 | 45.18M |
March 31, 2019 | 45.24M |
December 31, 2018 | 45.40M |
September 30, 2018 | 0.006M |
June 30, 2018 | 0.001M |
March 31, 2018 | -0.006M |
December 31, 2017 | 0.212M |
Date | Value |
---|---|
September 30, 2017 | 0.037M |
June 30, 2017 | -0.425M |
March 31, 2017 | -2.038M |
December 31, 2016 | -4.939M |
September 30, 2016 | -7.511M |
June 30, 2016 | -9.039M |
March 31, 2016 | -8.301M |
December 31, 2015 | -6.751M |
September 30, 2015 | -15.40M |
June 30, 2015 | -34.95M |
March 31, 2015 | -37.48M |
December 31, 2014 | -36.35M |
September 30, 2014 | -20.40M |
June 30, 2014 | -3.413M |
March 31, 2014 | 0.001M |
December 31, 2013 | 0.001M |
September 30, 2013 | -4.554M |
June 30, 2013 | -0.004M |
March 31, 2013 | -0.031M |
December 31, 2012 | -0.031M |
September 30, 2012 | -0.049M |
June 30, 2012 | -0.073M |
March 31, 2012 | -0.049M |
December 31, 2011 | -0.049M |
September 30, 2011 | -0.031M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-8.607M
Minimum
Jun 2021
45.18M
Maximum
Jun 2019
0.5748M
Average
-4.71M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |